{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 13223
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10011646",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20150326",
      "reporttype": "2",
      "serious": "1",
      "seriousnesscongenitalanomali": "1",
      "receivedateformat": "102",
      "receivedate": "20140314",
      "receiptdateformat": "102",
      "receiptdate": "20140806",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-JNJFOC-20140307569",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "JANSSEN",
        "duplicatenumb": "US-JNJFOC-20140307569"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "3"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientagegroup": "1",
        "patientweight": "3.22",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Foetal exposure during pregnancy",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Meningitis streptococcal",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Infarction",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "RETROVIR",
            "drugdosagetext": "2 MG/KG/HR",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20131129",
            "drugenddateformat": "102",
            "drugenddate": "20131129",
            "activesubstance": {
              "activesubstancename": "ZIDOVUDINE"
            },
            "openfda": {
              "application_number": [
                "NDA019655",
                "NDA019910",
                "NDA019951"
              ],
              "brand_name": [
                "RETROVIR"
              ],
              "generic_name": [
                "ZIDOVUDINE"
              ],
              "manufacturer_name": [
                "ViiV Healthcare Company"
              ],
              "product_ndc": [
                "49702-211",
                "49702-212",
                "49702-213"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL",
                "INTRAVENOUS"
              ],
              "substance_name": [
                "ZIDOVUDINE"
              ],
              "rxcui": [
                "108396",
                "198352",
                "201907",
                "204534",
                "755298",
                "756209"
              ],
              "spl_id": [
                "01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a"
              ],
              "spl_set_id": [
                "6df09f15-b102-431c-adde-d7aeef6f5d84"
              ],
              "package_ndc": [
                "49702-211-20",
                "49702-212-48",
                "49702-213-01",
                "49702-213-26"
              ],
              "nui": [
                "N0000175462",
                "N0000009947"
              ],
              "pharm_class_epc": [
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
              ],
              "unii": [
                "4B9XT59T7S"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "RETROVIR",
            "drugdosagetext": "1 MG/KG/HR",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20131129",
            "drugenddateformat": "102",
            "drugenddate": "20131129",
            "activesubstance": {
              "activesubstancename": "ZIDOVUDINE"
            },
            "openfda": {
              "application_number": [
                "NDA019655",
                "NDA019910",
                "NDA019951"
              ],
              "brand_name": [
                "RETROVIR"
              ],
              "generic_name": [
                "ZIDOVUDINE"
              ],
              "manufacturer_name": [
                "ViiV Healthcare Company"
              ],
              "product_ndc": [
                "49702-211",
                "49702-212",
                "49702-213"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL",
                "INTRAVENOUS"
              ],
              "substance_name": [
                "ZIDOVUDINE"
              ],
              "rxcui": [
                "108396",
                "198352",
                "201907",
                "204534",
                "755298",
                "756209"
              ],
              "spl_id": [
                "01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a"
              ],
              "spl_set_id": [
                "6df09f15-b102-431c-adde-d7aeef6f5d84"
              ],
              "package_ndc": [
                "49702-211-20",
                "49702-212-48",
                "49702-213-01",
                "49702-213-26"
              ],
              "nui": [
                "N0000175462",
                "N0000009947"
              ],
              "pharm_class_epc": [
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
              ],
              "unii": [
                "4B9XT59T7S"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "NORVIR",
            "drugstructuredosagenumb": "200",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20130901",
            "activesubstance": {
              "activesubstancename": "RITONAVIR"
            },
            "openfda": {
              "application_number": [
                "NDA022417",
                "NDA209512"
              ],
              "brand_name": [
                "NORVIR"
              ],
              "generic_name": [
                "RITONAVIR"
              ],
              "manufacturer_name": [
                "AbbVie Inc."
              ],
              "product_ndc": [
                "0074-2340",
                "0074-3333",
                "0074-1940",
                "0074-3399"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "RITONAVIR"
              ],
              "rxcui": [
                "152971",
                "199249",
                "900575",
                "900577",
                "1926066",
                "1926069"
              ],
              "spl_id": [
                "389fa9db-7528-4d2a-9518-8909d396177b"
              ],
              "spl_set_id": [
                "2849298e-de6e-47bb-8194-56e075b33fc3"
              ],
              "package_ndc": [
                "0074-3333-30",
                "0074-1940-63",
                "0074-3399-30",
                "0074-2340-30"
              ],
              "nui": [
                "N0000000246",
                "N0000191001",
                "N0000175889",
                "N0000190114",
                "N0000182137",
                "N0000185607",
                "N0000190118",
                "N0000185503",
                "N0000190113",
                "N0000182141",
                "N0000191266",
                "N0000185507",
                "N0000187064",
                "N0000190117"
              ],
              "pharm_class_moa": [
                "HIV Protease Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "UDP Glucuronosyltransferases Inducers [MoA]"
              ],
              "pharm_class_epc": [
                "Cytochrome P450 3A Inhibitor [EPC]",
                "Protease Inhibitor [EPC]"
              ],
              "unii": [
                "O3J8G9O825"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PREZISTA",
            "drugstructuredosagenumb": "800",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosageform": "TABLETS",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20130627",
            "drugenddateformat": "102",
            "drugenddate": "20130901",
            "drugrecurreadministration": "2",
            "activesubstance": {
              "activesubstancename": "DARUNAVIR ETHANOLATE"
            },
            "openfda": {
              "application_number": [
                "NDA021976",
                "NDA202895"
              ],
              "brand_name": [
                "PREZISTA"
              ],
              "generic_name": [
                "DARUNAVIR"
              ],
              "manufacturer_name": [
                "Janssen Products LP"
              ],
              "product_ndc": [
                "59676-562",
                "59676-563",
                "59676-564",
                "59676-566",
                "59676-565"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DARUNAVIR ETHANOLATE"
              ],
              "rxcui": [
                "670026",
                "794610",
                "831868",
                "831870",
                "850455",
                "850457",
                "1236628",
                "1236632",
                "1359269",
                "1359271"
              ],
              "spl_id": [
                "3d80bc62-24ac-c092-e063-6394a90a7bba"
              ],
              "spl_set_id": [
                "814301f9-c990-46a5-b481-2879a521a16f"
              ],
              "package_ndc": [
                "59676-563-01",
                "59676-564-01",
                "59676-562-01",
                "59676-566-30",
                "59676-565-01"
              ],
              "unii": [
                "33O78XF0BW"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ISENTRESS",
            "drugstructuredosagenumb": "800",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20130613",
            "activesubstance": {
              "activesubstancename": "RALTEGRAVIR POTASSIUM"
            },
            "openfda": {
              "application_number": [
                "NDA022145",
                "NDA203045",
                "NDA205786"
              ],
              "brand_name": [
                "ISENTRESS"
              ],
              "generic_name": [
                "RALTEGRAVIR"
              ],
              "manufacturer_name": [
                "Merck Sharp & Dohme LLC"
              ],
              "product_ndc": [
                "0006-0227",
                "0006-0477",
                "0006-0473",
                "0006-3603",
                "0006-3080"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "RALTEGRAVIR POTASSIUM"
              ],
              "rxcui": [
                "744842",
                "744846",
                "1235588",
                "1235591",
                "1235593",
                "1235595",
                "1486838",
                "1486841",
                "1924313",
                "1924315"
              ],
              "spl_id": [
                "70b9b593-db43-43ad-8808-a1c86c048145"
              ],
              "spl_set_id": [
                "89a5ec53-d956-4329-8004-0f40f51c88a3"
              ],
              "package_ndc": [
                "0006-0227-61",
                "0006-0477-61",
                "0006-0473-61",
                "0006-3603-01",
                "0006-3603-60",
                "0006-3603-61",
                "0006-3080-01"
              ],
              "unii": [
                "43Y000U234"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "TRUVADA",
            "drugstructuredosagenumb": "1",
            "drugstructuredosageunit": "032",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosageform": "TABLETS",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20130613",
            "activesubstance": {
              "activesubstancename": "EMTRICITABINE\\TENOFOVIR DISOPROXIL FUMARATE"
            },
            "openfda": {
              "application_number": [
                "NDA021752"
              ],
              "brand_name": [
                "TRUVADA"
              ],
              "generic_name": [
                "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE"
              ],
              "manufacturer_name": [
                "Gilead Sciences, Inc"
              ],
              "product_ndc": [
                "61958-0701",
                "61958-0703",
                "61958-0704",
                "61958-0705"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "EMTRICITABINE",
                "TENOFOVIR DISOPROXIL FUMARATE"
              ],
              "rxcui": [
                "476556",
                "639888",
                "1744001",
                "1744003",
                "1744005",
                "1744007",
                "1744009",
                "1744011"
              ],
              "spl_id": [
                "32422ee8-1cdc-4305-bb3e-0458472513fc"
              ],
              "spl_set_id": [
                "54e82b13-a037-49ed-b4b3-030b37c0ecdd"
              ],
              "package_ndc": [
                "61958-0701-1",
                "61958-0703-1",
                "61958-0704-1",
                "61958-0705-1"
              ],
              "nui": [
                "N0000175462",
                "M0015066",
                "N0000009947"
              ],
              "pharm_class_epc": [
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
              ],
              "pharm_class_cs": [
                "Nucleosides [CS]"
              ],
              "pharm_class_moa": [
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
              ],
              "unii": [
                "OTT9J7900I",
                "G70B4ETF4S"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "NORVIR",
            "drugstructuredosagenumb": "100",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20130627",
            "drugenddateformat": "102",
            "drugenddate": "20130901",
            "activesubstance": {
              "activesubstancename": "RITONAVIR"
            },
            "openfda": {
              "application_number": [
                "NDA022417",
                "NDA209512"
              ],
              "brand_name": [
                "NORVIR"
              ],
              "generic_name": [
                "RITONAVIR"
              ],
              "manufacturer_name": [
                "AbbVie Inc."
              ],
              "product_ndc": [
                "0074-2340",
                "0074-3333",
                "0074-1940",
                "0074-3399"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "RITONAVIR"
              ],
              "rxcui": [
                "152971",
                "199249",
                "900575",
                "900577",
                "1926066",
                "1926069"
              ],
              "spl_id": [
                "389fa9db-7528-4d2a-9518-8909d396177b"
              ],
              "spl_set_id": [
                "2849298e-de6e-47bb-8194-56e075b33fc3"
              ],
              "package_ndc": [
                "0074-3333-30",
                "0074-1940-63",
                "0074-3399-30",
                "0074-2340-30"
              ],
              "nui": [
                "N0000000246",
                "N0000191001",
                "N0000175889",
                "N0000190114",
                "N0000182137",
                "N0000185607",
                "N0000190118",
                "N0000185503",
                "N0000190113",
                "N0000182141",
                "N0000191266",
                "N0000185507",
                "N0000187064",
                "N0000190117"
              ],
              "pharm_class_moa": [
                "HIV Protease Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "UDP Glucuronosyltransferases Inducers [MoA]"
              ],
              "pharm_class_epc": [
                "Cytochrome P450 3A Inhibitor [EPC]",
                "Protease Inhibitor [EPC]"
              ],
              "unii": [
                "O3J8G9O825"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PREZISTA",
            "drugauthorizationnumb": "021976",
            "drugstructuredosagenumb": "1200",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosageform": "TABLETS",
            "drugadministrationroute": "064",
            "drugindication": "PROPHYLAXIS AGAINST HIV INFECTION",
            "drugstartdateformat": "102",
            "drugstartdate": "20130901",
            "drugrecurreadministration": "2",
            "activesubstance": {
              "activesubstancename": "DARUNAVIR ETHANOLATE"
            },
            "openfda": {
              "application_number": [
                "NDA021976",
                "NDA202895"
              ],
              "brand_name": [
                "PREZISTA"
              ],
              "generic_name": [
                "DARUNAVIR"
              ],
              "manufacturer_name": [
                "Janssen Products LP"
              ],
              "product_ndc": [
                "59676-562",
                "59676-563",
                "59676-564",
                "59676-566",
                "59676-565"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DARUNAVIR ETHANOLATE"
              ],
              "rxcui": [
                "670026",
                "794610",
                "831868",
                "831870",
                "850455",
                "850457",
                "1236628",
                "1236632",
                "1359269",
                "1359271"
              ],
              "spl_id": [
                "3d80bc62-24ac-c092-e063-6394a90a7bba"
              ],
              "spl_set_id": [
                "814301f9-c990-46a5-b481-2879a521a16f"
              ],
              "package_ndc": [
                "59676-563-01",
                "59676-564-01",
                "59676-562-01",
                "59676-566-30",
                "59676-565-01"
              ],
              "unii": [
                "33O78XF0BW"
              ]
            }
          }
        ]
      }
    }
  ]
}